We are live on ! Find out more
CRMD icon

CorMedix

35 hedge funds and large institutions have $1.56M invested in CorMedix in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3% more funds holding

Funds holding: 3435 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.41% less ownership

Funds ownership: 2.53%2.12% (-0.41%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

63% less capital invested

Capital invested by funds: $4.26M → $1.56M (-$2.7M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $40K

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
5
Reduced
7
Closed
7
Calls
Puts
$40K
Net Calls
-$40K
Net Calls Change
+$16K

CRMD Hedge Fund Activity: Q1 2018 in Review

35 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2018, worth a combined $1.56M — down 63% from $4.26M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CRMD positions and 7 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $101K. The largest seller was Virtu Financial, exiting entirely with an estimated $114K sold.

  • 35 institutional investors held CorMedix (CRMD) as of Q1 2018, up from 34 in Q4 2017.
  • Funds reported $1.56M of CorMedix stock for Q1 2018, down 63% quarter-over-quarter.
  • 8 funds opened new CorMedix positions in Q1 2018 and 7 closed out, a net change of +1 holder.
  • The largest CorMedix buyer in Q1 2018 was Citadel Advisors, an estimated $101K added.
  • The largest CorMedix seller in Q1 2018 was Virtu Financial, an estimated $114K sold.

Based on aggregated 13F filings for Q1 2018.